ABIOMED Inc (NASDAQ:ABMD) over-valued by 13%
| Website | http://www.abiomed.com/ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Fiscal Year End | Mar 31, 2020 |
| Market Cap | $15,098,559,488 |
| Beta | 1.3859 |
| Average Volume | $331,150 |
| Last Dividend | 0% |
| Price on Feb 4, 2021 | $333.81 |
| Autochartist™ Valuation | $289.49 |
| Conclusion |
13% over-valued |
| Download Report |
